Showing 1 - 12 results of 12 for search 'O. M. Tatarchuk', query time: 0.02s Refine Results
  1. 1
    Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases

    Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases by Yu.M. Stepanov, M.V. Stoikevych, O.M. Tatarchuk, T.S. Tarasova

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Relationships between ultrasonic, immunological changes in the progression of liver steatosis and fibrosis in patients with chronic diffusive liver diseases of various etiologies

    Relationships between ultrasonic, immunological changes in the progression of liver steatosis and fibrosis in patients with chronic diffusive liver diseases of various etiologies by Yu. M. Stepanov, V. I. Didenko, I. S. Konenko, O. M. Tatarchuk

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Characteristics of metabolic syndrome in the servicemen with erosive esophagitis in wartime conditions

    Characteristics of metabolic syndrome in the servicemen with erosive esophagitis in wartime conditions by L.M. Mosiychuk, O.M. Shevtsova, O.M. Tatarchuk, O.P. Petishko

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Cytokines, insulin resistance and arterial wall stiffness in assessing the course of non-alcoholic fatty liver disease

    Cytokines, insulin resistance and arterial wall stiffness in assessing the course of non-alcoholic fatty liver disease by Yu. M. Stepanov, V. I. Didenko, O. M. Tatarchuk, I. S. Konenko, O. P. Petishko

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Pathogenetic role of inflammation and insulin resistance in non-alcoholic fatty liver disease in obese children

    Pathogenetic role of inflammation and insulin resistance in non-alcoholic fatty liver disease in obese children by Yu. M. Stepanov, N. Yu. Zavhorodnia, O. M. Tatarchuk, I. A. Klenina, I. S. Konenko, O. P. Petishko

    Published 2022-11-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Evaluation of the state of small intestinal microbiota, pro- and anti-inflammatory cytokines, short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease in patients with immune response to SARS-CоV-2

    Evaluation of the state of small intestinal microbiota, pro- and anti-inflammatory cytokines, short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease in... by Yu.M. Stepanov, V.I. Didenko, I.A. Klenina, O.M. Tatarchuk, O.P. Petishko, R.M. Kyslova

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Diagnostic accuracy of apoptosis markers in non-alcoholic fatty liver disease in children

    Diagnostic accuracy of apoptosis markers in non-alcoholic fatty liver disease in children by Yu. M. Stepanov, N. Yu. Zavhorodnia, O. Yu. Zavhorodnia, V. B. Yahmur, O. M. Tatarchuk, O. P. Petishko

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Pancreatic function in children with non-alcoholic fatty pancreas disease

    Pancreatic function in children with non-alcoholic fatty pancreas disease by Yu. M. Stepanov, O. Yu. Lukianenko, N. Yu. Zavhorodnia, O. M. Tatarchuk, N. H. Hravirovska, I. A. Klenina

    Published 2019-02-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    New approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2

    New approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2 by V.I. Didenko, S.L. Melanich, I.A. Klenina, O.M. Tatarchuk, O.P. Petishko, H.I. Bocharov

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Association between calprotectin and volatile fatty acids in patients with inflammatory bowel diseases

    Association between calprotectin and volatile fatty acids in patients with inflammatory bowel diseases by Yu. M. Stepanov, I. A. Klenina, O. M. Tatarchuk, M. V. Stoikevych, Т. S. Tarasova, N. S. Fedorova, O. P. Petishko

    Published 2023-04-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Association between morphological manifestations of inflammatory bowel disease and biochemical markers of inflammation

    Association between morphological manifestations of inflammatory bowel disease and biochemical markers of inflammation by M. V. Stoikevych, Yu. A. Haidar, D. F. Mylostуva, I. A. Klenina, O. M. Tatarchuk, V. A. Karachynova

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Intestinal microbiota in obese children with non-alcoholic fatty liver disease depending on the gallbladder function

    Intestinal microbiota in obese children with non-alcoholic fatty liver disease depending on the gallbladder function by Yu. M. Stepanov, N. Yu. Zavhorodnia, O. M. Tatarchuk, I. A. Klenina, O. I. Hrabovska, E. V. Zyhalo, O. P. Petishko, N. S. Vishnarevska, V. V. Dolhopolova

    Published 2022-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: